Literature DB >> 18754035

Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice.

Takeshi Yoshioka1, Kinichi Imura, Makoto Asakawa, Minoru Suzuki, Itsuki Oshima, Tsutomu Hirasawa, Tsuneaki Sakata, Tatsuya Horikawa, Akinori Arimura.   

Abstract

We reported that the Gly573Ser substitution in transient receptor potential vanilloid 3 (TRPV3) led to increased ion channel activity in keratinocytes and caused spontaneous hairlessness in DS-Nh mice. DS-Nh mice also develop allergic and pruritic dermatitis. As the hairless and dermatitis phenotypes were both inherited in an autosomal dominant fashion and could not be segregated from each other, we speculated that TRPV3(Gly573Ser) might be responsible for the dermatitis. Here, we constructed TRPV3(Gly573Ser) transgenic mice, with a putative promoter sequence in the 5' region of TRPV3, to investigate the involvement of TRPV3 in the development of specific types of dermatitis. These transgenic mice spontaneously developed dermatitis, whereas wild-type mice did not display this phenotype when maintained under the same conditions. Histological and serological analyses were carried out to better understand the clinical features of TRPV3(Gly573Ser) transgenic mice. A physiological study revealed that TRPV3(Gly573Ser) induced a higher nerve growth factor response to heat. Finally, C57BL-Nh mice were used to investigate the penetrance of the TRPV3(Gly573Ser) gene for dermatitis. Interestingly, C57BL-Nh mice developed spontaneous scratching behavior, separately from the development of dermatitis. We propose that TRPV3(Gly573Ser) is a cause of pruritus and/or dermatitis associated with scratching, and suggest that TRPV3 may represent a therapeutic target in pruritic dermatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754035     DOI: 10.1038/jid.2008.245

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  52 in total

Review 1.  Chemosensory properties of the trigeminal system.

Authors:  Félix Viana
Journal:  ACS Chem Neurosci       Date:  2010-12-22       Impact factor: 4.418

Review 2.  TRP channels in the skin.

Authors:  Balázs I Tóth; Attila Oláh; Attila Gábor Szöllősi; Tamás Bíró
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  TRPV3: time to decipher a poorly understood family member!

Authors:  Bernd Nilius; Tamás Bíró; Grzegorz Owsianik
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

Review 4.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  An itch to be scratched.

Authors:  Kush N Patel; Xinzhong Dong
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 6.  Transient receptor potential channels as therapeutic targets.

Authors:  Magdalene M Moran; Michael Allen McAlexander; Tamás Bíró; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2011-08-01       Impact factor: 84.694

Review 7.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 8.  Trp channels and itch.

Authors:  Shuohao Sun; Xinzhong Dong
Journal:  Semin Immunopathol       Date:  2015-09-18       Impact factor: 9.623

9.  COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.

Authors:  Stefan Spyra; Anne Meisner; Michael Schaefer; Kerstin Hill
Journal:  Br J Pharmacol       Date:  2017-06-29       Impact factor: 8.739

10.  Role of TRPV3 in immune response to development of dermatitis.

Authors:  Kinichi Imura; Takeshi Yoshioka; Tsutomu Hirasawa; Tsuneaki Sakata
Journal:  J Inflamm (Lond)       Date:  2009-05-25       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.